These images highlight some of the stages and types of lipoedema
Originally presented at the American Diabetes Association (ADA) 82nd Scientific Sessions in 2022, the phase 3 SURMOUNT-1 trial was designed as a double-blind, randomized, controlled trial to assess the effects of 5 mg, 10 mg, or 15 mg of tirzepatide once weekly relative to placebo for weight loss
Potential Impact on Obesity-Related Conditions: Obesity is associated with an increased risk of various health conditions, such as cardiovascular disease, type 2 diabetes, and certain types of cancer
Monitoring parameters: Standard GLP-1 monitoring: weight, glycemic parameters, blood pressure, side effects
and transforming the most difficult-to-treat cancers into manageable diseases
Everyday stressors also take their toll